Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.

CONCLUSIONS: -The biomarker-based ABC-stroke score was well calibrated and consistently performed better than both the CHA2DS2VASc and ATRIA stroke scores. The ABC score should be considered an improved decision support tool in the care of patients with AF. Clinical Trial Registration-ClinicalTrials.gov identifier: ARISTOTLE; NCT00412984, ClinicalTrials.gov identifier: RE-LY; NCT00262600. PMID: 27569438 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27569438?dopt=Abstract

Source: Circulation - August 27, 2016 Category: Cardiology Authors: Oldgren J, Hijazi Z, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L Tags: Circulation Source Type: research

More News: Atrial Fibrillation | Cardiology | Clinical Trials | Stroke | Study